✦ LIBER ✦

Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs

✍ Scribed by Kenneth D. Brandt; Steven A. Mazzuca

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 98 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Translating osteoarthritis into numbers:

Translating osteoarthritis into numbers: The importance of alignment in knee radiography for clinical trials of structure-modifying drugs

✍ Kenneth D. Brandt 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Subject retention and adherence in a ran

Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug

✍ Mazzuca, Steven A. ;Brandt, Kenneth D. ;Katz, Barry P. ;Lane, Kathleen A. ;Bradl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Drug treatment of older people with affe

Drug treatment of older people with affective disorders in the community: lessons from an attempted clinical trial

✍ Tim Stevens; Cornelius Katona; Monica Manela; Vivienne Watkin; Gill Livingston 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Background. Depression and phobic anxiety disorders are the most common psychiatric disorders in people aged 65 and over. SSRI antidepressants are eective in treating both conditions in younger people, and in treating depression in hospital samples of older subjects. No studies have investigated the

Predicting cross-reactive immunological

Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience

✍ Deeksha S. Bali; Jennifer L. Goldstein; Suhrad Banugaria; Jian Dai; Joanne Macke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Presence of significant synovitis in rhe

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

✍ A. K. Brown; M. A. Quinn; Z. Karim; P. G. Conaghan; C. G. Peterfy; E. Hensor; R. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract ## Objective More timely and effective therapy for rheumatoid arthritis (RA) has contributed to increasing rates of clinical remission. However, progression of structural damage may still occur in patients who have satisfied remission criteria, which suggests that there is ongoing dise